ICH GCP - EU Clinical trials Registry

EudraCT Number: 2022-003588-55

Sponsor Protocol Number: 20221102

Start Date: 2024-10-14

Sponsor Name: Isala

Full Title: Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study

Medical condition: Oncology

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004633-21

Sponsor Protocol Number: APHP191047

Start Date: 2024-04-29

Sponsor Name: Assistance Publique -Hopitaux de Paris

Full Title:

Medical condition:

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2023-000005-12

Sponsor Protocol Number: CRCFC-TEICO.SA.2022

Start Date: 2024-02-21

Sponsor Name: AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

Full Title: An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in CYSTIC FIBROSIS PATIENTS

Medical condition: cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10011762	Cystic fibrosis	PT
	20.0	100000004862	10075981	Staphylococcus aureus infection	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-003922-27

Sponsor Protocol Number: PAM-UMCG-002

Start Date: 2024-02-08

Sponsor Name: University Medical Center Groningen (UMCG)

Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer

Medical condition: Primary uterine cancer characterized with dMMR

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-004238-20

Sponsor Protocol Number: CC21000

Start Date: 2024-02-06

Sponsor Name: Vejle Hospital

Full Title: BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease

Medical condition: COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10042613 - Surgical and medical procedures	10075530	Medical cannabis therapy	PT
	21.1	10038738 - Respiratory, thoracic and mediastinal disorders	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-004168-24

Sponsor Protocol Number: BETHESDaCD

Start Date: 2023-12-29

Sponsor Name: Medical University of Warsaw

Full Title: Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa

Medical condition: Crohn's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10017947 - Gastrointestinal disorders	10017947	Gastrointestinal disorders	SOC

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-003573-32

Sponsor Protocol Number: 2022/ABM/01/00027

Start Date: 2023-12-28

Sponsor Name: Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Full Title: A randomized, double-blind, placebo-controlled study to evaluate the effect of allopurinol on the risk of cardiovascular events in patients at high and very high cardiovascular risk, including the ...

Medical condition: hyperuricemia, hypertension, ischemic stroke, intracerebral haemorrhage, TIA, heart failure, peripheral arterial disease, atrial fibrillation, diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10027433 - Metabolism and nutrition disorders	10020907	Hyperuricemia	LLT
	20.0	10047065 - Vascular disorders	10020772	Hypertension	PT
	22.1	10029205 - Nervous system disorders	10061256	Ischaemic stroke	PT
	21.1	10029205 - Nervous system disorders	10044390	Transient ischaemic attack	PT
20.0	10007541 - Cardiac disorders	10019279	Heart failure	LLT
20.0	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT
27.1	10007541 - Cardiac disorders	10003658	Atrial fibrillation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2013-000356-18

Sponsor Protocol Number: 25051974

Start Date: 2023-12-21

Sponsor Name: Stichting Apotheek der Haarlemse Ziekenhuizen

Full Title: Effect of repeated intranasal cobalamin administration on cobalamin deficiency in elderly

Medical condition: Cobalamin (vitamin B12) deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2022-003046-13

Sponsor Protocol Number: 2021/ABM/03/00008

Start Date: 2023-11-27

Sponsor Name: Śląskie Centrum Chorób Serca

Full Title: Sacubitril/Valsartan in PriMAry preventIoN of the cardiotoxicity of systematic breaST canceR trEAtMent. Randomized, multicenter, double-blind, placebo-controlled study.

Medical condition: Heart failure – post-anthracycline cardiomyopathy

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10019279	Heart failure	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-002955-20

Sponsor Protocol Number: ADENO-beta

Start Date: 2023-11-22

Sponsor Name: AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO

Full Title: Double-blind randomized controlled study versus placebo to evaluate the efficacy of mono-administration of betamethasone in children with symptomatic Adenovirus infection (ADENO-beta).

Medical condition: Pediatric patients diagnosed with symptomatic Adenovirus infection.

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10021881 - Infections and infestations	10060931	Adenovirus infection	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: IT (Trial now transitioned)

Trial results: (No results available)

Senaste försöken

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner